Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Northbaze Group | NBZ | 22. nov 2024 | 0.22 | -2.70 |
Northern CapSek Ventures | CAPS | 22. nov 2024 | 0.19 | 0.00 |
Northern CapSek Ventures PREF | CAPSPREF | 22. nov 2024 | 0.43 | -2.27 |
Northgold | NG | 22. nov 2024 | 0.68 | -8.16 |
Norva24 | NORVA | 22. nov 2024 | 27.25 | +2.83 |
Nosa Plugs | NOSA | 22. nov 2024 | 0.60 | +1.68 |
Nosium | NOSIUMB | 22. nov 2024 | 7.64 | +0.26 |
Note | NOTE | 22. nov 2024 | 127.30 | +0.87 |
Novotek B | NTEKB | 22. nov 2024 | 67.00 | +0.60 |
Novus Group | NOVU | 22. nov 2024 | 3.30 | -9.34 |
Nowonomics | NOWO | 22. nov 2024 | 3.20 | 0.00 |
NP3 Fastigheter | NP3 | 22. nov 2024 | 246.50 | +4.89 |
NP3 Fastigheter Pref | NP3PREF | 22. nov 2024 | 30.10 | +1.01 |
NYAB | NYAB | 22. nov 2024 | 5.39 | +4.66 |
Nyfosa | NYF | 22. nov 2024 | 103.00 | +2.49 |
Obducat B | OBDUB | 22. nov 2024 | 1.07 | +1.42 |
Observit | OBSE | 22. nov 2024 | 0.46 | +4.91 |
ODI Pharma | ODI | 22. nov 2024 | 3.20 | -3.03 |
Odinwell | ODIN | 22. nov 2024 | 2.78 | +0.72 |
OEM International B | OEMB | 22. nov 2024 | 118.40 | +2.25 |
Ogunsen B | OGUNB | 22. nov 2024 | 31.30 | +0.64 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | 22. nov 2024 | 301.49 | +0.77 |
OMX NORDIC 40 | OMXN40 | 22. nov 2024 | 2 615.49 | +2.04 |
OMX Oslo 20 GI | OMXO20GI | 22. nov 2024 | 1 336.85 | +0.11 |
OMX Oslo 20 PI | OMXO20PI | 22. nov 2024 | 737.86 | +0.11 |
OMX Stockholm 30 | OMXS30 | 22. nov 2024 | 2 514.10 | +0.71 |
OMX Stockholm 30 GI | OMXS30GI | 22. nov 2024 | 493.56 | +0.71 |
OMX Stockholm 60 Cap PI | OMXS60CAP | 22. nov 2024 | 309.46 | +0.92 |
OMX Stockholm 60 PI | OMXS60PI | 22. nov 2024 | 290.80 | +0.91 |
OMX Stockholm Automobiles & Parts PI | SX4010PI | 22. nov 2024 | 1 197.15 | +2.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.